» Articles » PMID: 25153692

Amplification of Tau Fibrils from Minute Quantities of Seeds

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2014 Aug 26
PMID 25153692
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The propagation of Tau pathology in Alzheimer's disease (AD) is thought to proceed through templated conversion of Tau protein into fibrils and cell-to-cell transfer of elongation-competent seeds. To investigate the efficiency of Tau conversion, we adapted the protein misfolding cyclic amplification assay used for the conversion of prions. Utilizing heparin as a cofactor and employing repetitive cycles of shearing and growth, synthetic Tau fibrils and Tau fibrils in AD brain extract are progressively amplified. Concurrently, self-nucleation is suppressed. The results highlight breakage-induced replication of Tau fibrils as a potential facilitator of disease spread.

Citing Articles

Cellular Uptake of Tau Aggregates Triggers Disulfide Bond Formation in Four-Repeat Tau Monomers.

Krzesinski B, Holub T, Gabani Z, Margittai M ACS Chem Neurosci. 2024; 16(2):171-180.

PMID: 39714208 PMC: 11740991. DOI: 10.1021/acschemneuro.4c00607.


The Role of Tau Pathology in Alzheimer's Disease and Down Syndrome.

Granholm A, Hamlett E J Clin Med. 2024; 13(5).

PMID: 38592182 PMC: 10932364. DOI: 10.3390/jcm13051338.


Roles of Nucleic Acids in Protein Folding, Aggregation, and Disease.

Litberg T, Horowitz S ACS Chem Biol. 2024; 19(4):809-823.

PMID: 38477936 PMC: 11149768. DOI: 10.1021/acschembio.3c00695.


MAP2 caps tau fibrils and inhibits aggregation.

Holden M, Krzesinski B, Weismiller H, Shady J, Margittai M J Biol Chem. 2023; 299(7):104891.

PMID: 37286038 PMC: 10404690. DOI: 10.1016/j.jbc.2023.104891.


In Vitro Amplification of Pathogenic Tau Seeds from Neurodegenerative Disease Patient Brains.

Xu H, Lee V Methods Mol Biol. 2022; 2561:279-292.

PMID: 36399276 DOI: 10.1007/978-1-0716-2655-9_15.


References
1.
Kuret J, Congdon E, Li G, Yin H, Yu X, Zhong Q . Evaluating triggers and enhancers of tau fibrillization. Microsc Res Tech. 2005; 67(3-4):141-55. DOI: 10.1002/jemt.20187. View

2.
Saborio G, Permanne B, Soto C . Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature. 2001; 411(6839):810-3. DOI: 10.1038/35081095. View

3.
Wischik C, Novak M, Thogersen H, Edwards P, Runswick M, Jakes R . Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A. 1988; 85(12):4506-10. PMC: 280459. DOI: 10.1073/pnas.85.12.4506. View

4.
Novak M, Kabat J, Wischik C . Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. EMBO J. 1993; 12(1):365-70. PMC: 413214. DOI: 10.1002/j.1460-2075.1993.tb05665.x. View

5.
Siddiqua A, Luo Y, Meyer V, Swanson M, Yu X, Wei G . Conformational basis for asymmetric seeding barrier in filaments of three- and four-repeat tau. J Am Chem Soc. 2012; 134(24):10271-8. PMC: 3381011. DOI: 10.1021/ja303498q. View